Marshall Wace North America’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-86,123
| Closed | -$2.5M | – | 1354 |
|
|
2021
Q1 | $2.5M | Sell |
86,123
-68,565
| -44% | -$1.99M | 0.01% | 748 |
|
|
2020
Q4 | $3.99M | Hold |
154,688
| – | – | 0.02% | 589 |
|
|
2020
Q3 | $4.76M | Buy |
+154,688
| New | +$4.76M | 0.03% | 406 |
|
|
2020
Q2 | – | Sell |
-2,939
| Closed | -$62K | – | 1132 |
|
|
2020
Q1 | $62K | Buy |
+2,939
| New | +$62K | ﹤0.01% | 1055 |
|
|
2019
Q3 | – | Sell |
-54,304
| Closed | -$1.04M | – | 1292 |
|
|
2019
Q2 | $1.04M | Buy |
+54,304
| New | +$1.04M | 0.01% | 738 |
|